Surrogate-guided sampling designs for classification of rare outcomes
  from electronic medical records data by Tan, W. Katherine & Heagerty, Patrick J.
Surrogate-guided sampling designs for classification of
rare outcomes from electronic medical records data
W. KATHERINE TAN∗, PATRICK J. HEAGERTY
Abstract
Scalable and accurate identification of specific clinical outcomes has been enabled by
machine-learning applied to electronic medical record (EMR) systems. The develop-
ment of automatic classification requires the collection of a complete labeled data set,
where true clinical outcomes are obtained by human expert manual review. For exam-
ple, the development of natural language processing algorithms requires the abstraction
of clinical text data to obtain outcome information necessary for training models. How-
ever, if the outcome is rare then simple random sampling results in very few cases and
insufficient information to develop accurate classifiers. Since large scale detailed ab-
straction is often expensive, time-consuming, and not feasible, more efficient strategies
are needed. Under such resource constrained settings, we propose a class of enrichment
sampling designs, where selection for abstraction is stratified by auxiliary variables re-
lated to the true outcome of interest. Stratified sampling on highly specific variables
results in targeted samples that are more enriched with cases, which we show translates
to increased model discrimination and better statistical learning performance. We pro-
vide mathematical details, and simulation evidence that links sampling designs to their
resulting prediction model performance. We discuss the impact of our proposed sam-
pling on both model development and validation. Finally, we illustrate the proposed
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designs for outcome label collection and subsequent machine-learning, using radiology
report text data from the Lumbar Imaging with Reporting of Epidemiology (LIRE)
study.
1 Introduction
Linked electronic medical record (EMR) systems provide a massive reservoir of information
that can help researchers understand and treat both common and rare medical conditions.
Specifically, EMR data includes both structured data, such as lab values and diagnostic
codes, and unstructured data in the form of free-text medical notes and images. The ma-
jority of EMR data is natively captured in unstructured form, and this has fostered the
development of learning algorithms to extract research ready variables (Pons et al. [2016],
Wang et al. [2018]). Both structured and unstructured data may be used towards identifi-
cation of key clinical indicators or outcomes, where accurately-derived outcomes can greatly
improve downstream analyses such as the generation of prognostic models for disease risk, or
predictive scores that could guide treatment. Ultimately both structured data and carefully
processed unstructured data are necessary, but extracting specific findings from unstruc-
tured data is often expensive and time-consuming. The traditional approach requires highly
trained clinicians or technicians who can transcribe medical notes into coded variables. The
manual abstraction process is not scalable to massive EMR cohorts and has motivated using
machine-learning methods, such as natural language processing (NLP) methods for medical
text data (Chapman et al. [2001], Carroll et al. [2012]), and deep learning strategies for
medical images (Esteva et al. [2017]), as scalable alternatives. Yet, any algorithm develop-
ment relies on a base of training and validation data, and the purpose of this manuscript
is to outline efficient study designs that can facilitate cost-effective data collection for the
development of new prediction tools.
In order to both develop (i.e. train) and validate (i.e. test) data-driven machine-learning
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algorithms requires “labeled data”, which is a sample containing both feature (predictor)
and outcome information. For example, classification of imaging findings from radiology
report text may use word indicators as features and clinician-defined actual case/control
statuses as binary outcomes. In typical EMR settings, labeled data is not readily available,
therefore a small subset of the underlying cohort needs to be selected for outcome abstrac-
tion. The information content in labeled samples is crucial towards efficient and accurate
machine-learning modeling. For classification tasks, a well-known challenge for training is
statistical rarity, where cases (outcome=1) are disproportionately less frequent than con-
trols (outcome=0), and the fact that the training sample outcome class distribution may
affect classification accuracy has been demonstrated both empirically (Weiss and Provost
[2001], Batista et al. [2004], Wei and Dunbrack Jr [2013]) and theoretically (Xue and Hall
[2015]). Unsurprisingly, such class distributional “imbalance” is almost always observed for
clinical outcomes. One approach in the machine-learning literature that has been proposed
to address statistical rarity involves re-sampling the training sample to eliminate controls
(under-sampling) or replicating cases (over-sampling), in order to re-balance the effective
outcome class distribution in training, and hopefully to improve ultimate model prediction
accuracy (Chawla et al. [2002], He and Garcia [2009]). However, such analysis-based re-
sampling procedures assume that an initial labeled data sample is already available, and
these strategies disregard the potential cost associated with labeled data collection (Weiss
and Provost [2001]).
When data collection resources are scarce, targeted sampling methods in epidemiology have
offered highly efficient research designs. In contrast to analysis-based re-sampling proce-
dures, epidemiologic sampling methods are defined at the design stage of studies prior to
data collection. One well-known sampling method is the case-control design (Prentice and
Pyke [1979]), where collected samples may be appropriately analyzed using a logistic regres-
sion model, and has the attractive advantage that estimation proceeds as if a simple random
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sample were collected (although the regression intercept is biased). Sampling designs such as
the case-control, where expensive data ascertainment is based on strata defined by values of a
cheaper auxiliary variable, may be viewed as special cases of the general two-phase sampling
design (Neyman [1934], Chatterjee et al. [2003]). In the context of effect estimation, targeted
sampling through two-phase has been shown to provide efficiency over simple random sam-
pling (Zhao et al. [2009], McIsaac and Cook [2014]), especially when using sampling variables
that are highly correlated and informative for the outcome (Zhao et al. [2012]). However, the
effect of selectively sampled training data on ultimate machine-learning prediction accuracy
has not been thoroughly investigated.
For clinical outcome identification using EMR data, an imperfect alternative to abstracted
outcomes may be based on summaries of related structured data elements, such as Inter-
national Classification of Disease (ICD) codes and simple keyword searches queried within
pre-specified time frames. Such “surrogates” or “correlates” of actual clinical outcomes have
been used in place of true clinical outcomes in machine-learning modeling tasks to reduce
the dimensionality of EMR-generated features (Yu et al. [2016]), or directly as “noisy” im-
puted outcome labels for classifier development (Agarwal et al. [2016]). However, model
development with misclassified outcomes may seriously compromise validity of using the re-
sulting model predictions for downstream analyses (Sinnott et al. [2014]), therefore using
surrogates to replace abstracted clinical outcomes as labels may not be justified. Alterna-
tively, surrogates could help guide selection of subjects for labeled data abstraction. In fact,
subject selection based on non-negated keywords and ICD codes has been described when
assembling a labeled data sample for machine-learning classification of clinical outcomes
(Pakhomov et al. [2005]). Yet, there remains little discussion of corresponding statistical
rationale, and such heuristic decisions based on purposeful biased sampling may not create
generalizable predictions, or valid summaries of accuracy.
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This paper is motivated by the need for a formal statistical framework to guide sampling of
subjects for labeled data abstraction, towards accurate and scalable machine-learning clas-
sification of clinical outcomes. We specifically focus on the rare outcome scenario, where
model accuracy is often rate-limited by the number of outcome cases. As with conventional
intuition, our proposed strategy targets case-enrichment of rare outcomes for selection of
training data. The key contribution of our work is the formalization of heuristic sampling
methodologies drawn from the fields of machine-learning and epidemiology, therefore filling
a critical gap in EMR research methods. In Section 2.1, we frame the statistical problem
and describe the proposed sampling framework. Then, in Section 2.2 we provide a represen-
tation of development sample composition on model discrimination and demonstrate direct
connections with statistical efficiency. In Section 2.3, we describe configurations within the
class of proposed designs that are best for learning, and characterize the sampling impact
for both model development and validation in Section 2.4. We provide empirical evidence
through simulations in Section 3. Finally, in Section 4 we illustrate the method on a data set
of lumbar spine imaging reports that was obtained in a pragmatic trial of radiology decision
support (Jarvik et al. [2015]), and provide a concluding discussion in Section 5.
2 Methods
2.1 Statistical motivation and proposed design
For subject i denote X˜i ∈ Rp as the feature vector and Yi ∈ {0, 1} as the binary outcome.
The general classification problem is to find function h(.) that maps from the features to
outcomes, for example penalized logistic regression
βˆ0,
ˆ˜βX = min
β0,β˜X
{−
n∑
i=1
Yi(β0 +
p∑
j=1
βXjXij) + log(1 + exp(β0 +
p∑
j=1
βXjXij)) + λ
p∑
j=1
||βj||L}. (1)
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where in (1), L = 1 refers to Lasso regression (Tibshirani [1996]) and L = 2 refers to Ridge
regression (Le Cessie and Van Houwelingen [1992]). For a concrete example of application of
classification models such as (1), consider the task of classifying radiology reports for subject
vertebral fracture status. For this natural language processing (NLP) motivated task, simple
features X˜Ti may be derived using bag-of-words (BOW) representations, while outcomes Yi
obtained through abstraction. More sophisticated feature engineering is common in NLP,
but for the characterization of efficient designs we illustrate using a simple learning approach.
For subject i, the BOW feature vector X˜i has binary elements Xij = I(tj ∈ reporti) with
unique terms tj obtained by concatenating all reports, while the abstracted outcome label
Yi is the clinician-defined indicator of vertebral fracture. For data required towards fitting
(1), note that while extracting features is relatively cheap, obtaining outcome statuses is
time-consuming. Therefore, for clinical outcome identification tasks, a sample needs to be
drawn from the EMR cohort D for outcome abstraction so that both X˜i and Yi are available
for machine-learning development and evaluation.
Denote the sample DS(n), having sample size n and sampling design S. Typically, the as-
sumption on S is simple random sampling (SRS) from D. However, due to the expected
low number of cases from naturally rare clinical outcomes, using SRS to select reports for
abstraction is often inadequate. In machine-learning a common procedure is oversampling
to artificially increase sample prevalence where cases are randomly replicated at the analysis
stage. However, oversampling does not generate new information, rather simply re-weighs
existing data.
Alternatively, samples with higher outcome prevalence can be collected by design through
stratified sampling. For the development of outcome classification algorithms using EMR
data, recall that while true Yi requires abstraction from unstructured data, there exists other
structured data elements in the database that are related to Yi. For instance, true outcome
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status for the example of vertebral fracture identification may be related to counts of related
keywords in report text, or related to International Classification of Disease (ICD) codes
recorded during the same subject visit. Denote summaries of such related structured data
elements as Zi, where it is reasonable to expect Zi to be associated with true Yi, and therefore
a “surrogate for the true outcome. However, due to the potential misclassification of Zi for
Yi, instead of replacing Yi by Zi we suggest using Zi as auxiliary variables for sampling to
develop a prediction model.
Definition 1 Surrogate-guided sampling (SGS) design class.
Denote the surrogate-guided sampling (SGS) design class as the set of stratified sampling
procedures based only on values of a binary enrichment surrogate Z ∈ {0, 1}. Such designs
would select an individual for sampling with probability pi(Zi) where typically pi(Zi = 1) >
pi(Zi = 0) when Z is positively correlated with Y .
The surrogate-guided sampling (SGS) design class (Definition 1) describes the class of strat-
ified sampling designs based on values of an enrichment surrogate, and is a special case of
two-phase sampling. To conduct an SGS design, all subjects in the cohort are divided into
two strata based on surrogate values: surrogate positives with Zi = 1, and surrogate nega-
tives with Zi = 0. Then, subjects are selected into the sample based on surrogate values, and
only selected subjects have true Yi abstracted for. The intended benefit of SGS designs is
that, for the same abstraction cost, resulting samples have higher expected outcome preva-
lences compared to using SRS. For illustration, consider an outcome prevalence of 10%, and
assume that in the EMR, there exists a surrogate with 40% sensitivity and 95% specificity
for the outcome of interest. For an abstraction budget of collecting n = 500 labels, using an
SGS design with three-times as many surrogate positives as surrogate negatives yields about
185 true cases in expectation. In contrast, an SRS design would have required abstraction
of almost 1850 subjects to yield 185 actual cases, abstraction burden of close to four times.
Note that cases identified using SGS designs are true cases collected from the cohort, and
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not replicates or synthetic data as resulting from using analysis-based re-balancing methods.
We now describe theoretical and analytical results that are key to understanding our pro-
posed sampling framework. First, in order to demonstrate that the sampling design choice
does affect learning performance, we provide a mathematical representation of how training
sample composition affects prediction accuracy. Second, among the possible designs in the
proposed SGS sampling class, we investigate configurations that improve sampling benefit
for learning. Intuitively as illustrated in Figure 1, when the case proportion is higher in
the surrogate positive (Z = 1) compared to the surrogate negative (Z = 0) stratum, over-
representing the surrogate positive stratum provides higher expected sample case proportion
by construction - we provide an analytical treatment of such intuition. Lastly, we characterize
the impact of using the proposed SGS design on machine-learning performance, describing
bias and modeling considerations for both model development and model validation.
2.2 Effect of training sample composition on prediction accuracy
To statistically motivate that sampling design choice does affect learning performance, we
provide a mathematical representation of how training sample composition impacts predic-
tion accuracy. For tractability we focus on a commonly used evaluation metric, the Area
Under the Receiver Operating Characteristic (ROC) Curve (AUC). Model validation AUC
can be interpreted as how well resulting continuous predictions discriminate between ran-
domly selected pairs of case and control subjects in yet unseen data. Other performance
metrics such as binary accuracy correspond to the sum of error values for an optimal point
on the ROC curve. If we consider continuous model predictions as a “test” for true outcome
statuses, then under a bi-normal assumption, Pepe [2003] has shown the AUC to be
AUC = Φ(
√
RAUC) = Φ
(√
(µ1 − µ0)2
σ21 + σ
2
0
)
. (2)
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In (2), µy and σ
2
y are the means and variances of the “test” among the cases (y = 1) and
controls (y = 0). The bi-normal AUC formula (2) was developed in Pepe [2003] for diagnos-
tic testing applications, but may be generalized to the classification modeling setting. For
classification model development, the continuous “test” is estimated using a development
sample, but generalizable performance usually evaluated on a separate validation sample.
Therefore, we introduce additional notation to express such differences between the classifi-
cation modeling and diagnostic testing settings. Denote DS(n) as the development sample
collected using sampling design S and having sample size n, and assume that the validation
sample is a large sample obtained through SRS from D. Then, the validation AUC for model
developed with DS(n) may be represented using an indexing as shown in Definition 2.
Definition 2 AUC(Y |DS(n)).
Let AUC(Y |DS(n)) denote the validation AUC of a classification model for outcome Y
developed using sample DS(n) defined with sampling design S and sample size n.
Using the indexing as in Definition 2, we may then represent validation AUC in terms of
development sample composition, assuming bi-normally distributed features ((X|Y = y) ∼
N(µx|y,Σx|y)). Theorem 1 shows that validation AUC is inversely proportional to the es-
timation variance and the data signal-to-noise ratio. Therefore, assuming use of the same
modeling procedure, using a design with higher statistical information as measured by lower
estimation variance results in higher validation AUC. To our knowledge, the results in Theo-
rem 1 are the first to directly present an indexing of validation AUC in terms of development
sample composition. Note that our argument for Theorem 1 may be generalized beyond bi-
normal features and logistic regression. For example, the bi-normal features assumption may
be relaxed to allow for monotone transformations of normal distributions (Pepe [2003]). In
addition, the results in Theorem 1 may be applied to penalized logistic regression, as long
as the estimation bias and variance of resulting coefficients can be well characterized.
9
Theorem 1 Assume that in D, for y ∈ {0, 1}, (X|Y = y) ∼ N(µTx|y,Σx|y), where µx|y=0 = 0
and Σx|y=1 = Σx|y=0 = Σx|y. Let ηˆ = Xβˆ be the estimated linear predictor, where model
coefficients βˆ are estimated by logistic regression using development sample DS(n). Then,
AUC(Y |DS(n)) ∝ 1
trace(σV (βˆS(n)) + µTV (βˆS(n))µ
, (3)
where V (βˆS(n)) = (XTWX)−1 is the approximate covariance matrix of estimating βˆ using
DS(n), and µ = µx|y1 and σ = Σx|y are parameters describing the data signal-to-noise ratio.
We may use the results in Theorem 1, to explain the effect of outcome class imbalance
on classifier discrimination. When modeling using logistic regression, it has been noted
that samples with rare outcomes tend to result in more highly variable coefficient estimates
compared to that of more prevalent outcomes (King and Zeng [2001]). As demonstrated in
(3), such increased estimation variance directly results in lower discrimination. To increase
discrimination in validation requires using an alternative sampling design S that results in
lower variability in estimating βˆ, a higher information design. In the context of two-phase
sampling designs, the choice of sampling variable as well as strata proportions may affect
design information we now turn to discussion on this point.
2.3 Quantifying SGS design benefit with Oratio.
For a parametric regression model we demonstrated that the development sample com-
position affects ultimate model validation AUC through the variance associated with the
estimation of risk scores. In general, to directly quantify the effect of sampling design on
estimation variance requires numerical approximations. Alternatively, motivated by empir-
ical results in machine-learning, we turn to sample outcome prevalence as another simple
measure of information. We now focus on characterizing the “effect” of a sampling design
on the sample outcome prevalence. Let Si = 1 denote that subject i was selected for sam-
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pling using design DS(n). The sample case/control odds, E[Y |S=1]
1−E[Y |S=1] , compares the expected
proportion of cases to controls among sampled subjects (S = 1), where higher odds indicate
higher prevalence. To denote the sample case enrichment comparing SGS to SRS, we propose
using the case/control odds ratio, a metric we denote as Oratio and mathematically define in
Definition 3.
Definition 3 Oratio.
Let Oratio denote the expected case/control odds ratio comparing surrogate-guided sampling
(SGS) to simple random sampling (SRS), where Oratio =
ED
SGS(n)[Y |S=1]
1−EDSGS(n)[Y |S=1]/
ED
SRS(n)[Y |S=1]
1−EDSRS(n)[Y |S=1] =
Odds(cases|SGS)
Odds(cases|SRS) .
The denominator of Oratio is the expected odds of cases for samples collected with SRS,
and is assumed to be less than 1 for rare outcomes. The numerator is the expected odds
of cases for samples collected with SGS designs. Therefore, Oratio can be interpreted as the
expected increase in cases comparing SGS to SRS, with higher values indicating that SGS
provides more case enrichment, and Oratio > 1 indicating improvement using SGS relative to
SRS. Oratio has similarities and differences to the term “odds ratio” which is often used in
epidemiology. The epidemiological usage of “odds ratio” compares the case/control odds of
a sample drawn from the exposed group to a sample drawn from the unexposed group, and
provides a single estimate of exposure effect. Similar to the exposure odds ratio, Oratio also
compares the case/control odds of two samples drawn from the same population. However,
since the samples are defined by sampling design instead of exposure statuses, the Oratio
provides a single estimate of design effect on sample outcome prevalence. Therefore, Oratio
provides a one-dimensional summary measure of case enrichment comparing SGS over SRS.
2.3.1 Properties of Oratio and the impact of surrogate specificity
An interesting property of Oratio is the connection to Likelihood Ratios (LRs) of the enrich-
ment surrogate. Of note, LRs of a diagnostic test can be interpreted as slopes of Receiver
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Operating Characteristics (ROC) curves, are related to positive and negative predictive val-
ues (PPV & NPV), but are invariant to outcome prevalence (Choi [1998]). Therefore, by
framing enrichment surrogates Z as “prior tests” of outcome Y , we may gain insight into
what types of variables are the best surrogates for sampling.
Proposition 1 Properties of Oratio.
Let a surrogate-guided sampling (SGS) design of sample size n be defined with surrogate Z
and sampling ratio R = P (Z = 1|S = 1), where Z has pZ := P (Z = 1) and operating
characteristics: Zsens := P (Z = 1|Y = 1), Zspec = P (Z = 0|Y = 0). Then,
Oratio(n,R, Z) =
RZsens + pZ(1−R− Zsens)
R(1− Zspec) + pZ(Zspec −R) . (4)
Additionally, if the outcome is rare (P (Y = 1) ≈ 0), then
Oratio(n,R, Z) ≈ (R)(LR+) + (1−R)(LR−). (5)
Corollary 1 For a given Z, Oratio ∝ R. Over the set of possible Z, Oratio ∝ Zsens and
Oratio ∝ 1
1− Zspec .
Equation (5) in Proposition 1 shows that Oratio is approximately the sum of positive and
negative surrogate likelihood ratios (LR+ = Zsens
1−Zspec and LR− = 1−ZsensZspec ), weighted by the
sample proportion of surrogate positives. Corollary 1 follows directly from (5), and directly
characterizes the effect of both strata allocation and sampling variable choice on sample case
enrichment. For strata allocation, over-representing surrogate positives (higher R) results
in higher values of Oratio. In terms of sampling variable choice, notice that for any given
R, while the rate of increase in Oratio is linear in Zsens it is inverse polynomial in 1− Zspec.
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Therefore, a small change in specificity can have a much higher impact on Oratio compared
to the same change in sensitivity. Another perspective on sampling variable choice may be
obtained by translating sensitivities and specificities into likelihood ratios. In general, while
a “good” test requires having high values of both LR+ and LR−, having a high LR+ alone
is sufficient to achieve a high Oratio: requirements for a variable to be a good enrichment
surrogate for sampling are weaker than requirements for a good diagnostic test.
The illustration in Figure 2 emphasizes the impact of surrogate specificity on Oratio, where
values of Oratio are indicated by different colors across possible ranges of surrogate marginal
sensitivities and specificities for an SGS design with fixed R = 0.50. The non-gray regions of
Figure 2 illustrates operating characteristics of surrogates that constitute good candidates for
stratified sampling variables. We excluded the presentation of surrogates with specificities
less than 0.50, as we may redefine these surrogates to obtain a more specific variable. From
Figure 2, note that when using surrogates with specificities of 0.80 or higher, case-enrichment
relative to SRS can be expected even with sensitivities as low as 0.20. Our mathematical
analyses convey two important practical implications. First, if there exists a dichotomous
variable in the EMR that predicts the outcome better than random noise, stratified sampling
based on such a variable can provide a development sample that is more enriched for cases,
for the same abstraction cost of a simple random sample. Second, to improve on case
enrichment, optimizing the enrichment surrogate for high specificity provides much more
value compared to optimizing for high sensitivity. By stratified sampling on the values of an
enrichment surrogate that is highly specific for the outcome of interest, SGS designs result
in development samples with higher outcome prevalence, which may correspond to increased
statistical information, lower estimation variance, and therefore improved statistical learning.
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2.4 Design impact on model development and model validation
To improve the information of samples selected for machine-learning, SGS designs inten-
tionally over-represent surrogate positives. A natural concern is whether such introduced
selection bias may impact the validity of developed models. The impact of sample character-
istics on machine-learning was first formalized in Zadrozny [2004], and can be formulated as
a missing data problem (Little and Rubin [2014]). Recall that sampling in SGS only depends
on surrogate values Z, which are assumed to be available for all subjects in D. Therefore, for
the SGS design, sampling is independent of outcome labels conditional on surrogate values,
equivalently S ⊥ Y |Z, an assumption also known as Missing At Random (MAR). Using
the MAR assumption, we now describe the impact of using SGS designs for both model
development and model validation.
2.4.1 Design impact on model development
To characterize design impact on model development, we consider distributional differences
between the development sample and the cohort. For sample DS(n) obtained with sampling
design S, Zadrozny [2004] suggested that S may be used for developing model hˆ(.) “validly”
under the asymptotic equivalence criteria, with lim
n→∞
hˆ(DS(n)) = h(D), where as the devel-
opment sample size n grows, the hˆ(.) approaches the truth h(.) as if the full cohort were
available. In particular, S resulting in DS(n) having outcomes MAR from D are “valid”
for model development of classifiers based on conditional means in the asymptotic “true
model” sense (Zadrozny [2004]). Note that for logistic regression, logit(E[Y |X, Z, S = 1]) =
logit(E[Y |X, Z]), therefore, machine-learning model development with logistic regression
using SGS samples will result in validly estimated models under this interpretation.
2.4.2 Design impact on model validation
Now, consider the impact of using sample DS(n), where S is the SGS design, on model
validation to assess prediction performance. This practically relevant scenario may arise, for
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example, when a single sampling design is used to select subjects for outcome abstraction,
and then resulting sample split into separate sub-samples for model development and model
validation. On the validation sample, the developed model may be assessed for its prediction
accuracy, using metrics such as sensitivity, specificity, and AUC.
In general, unless the validation sample is drawn randomly from the cohort (i.e. SRS),
empirically estimated accuracy metrics are typically biased for the true values. However,
for validation samples collected using SGS, due to the MAR assumption bias-correction
methods are available. For example, the Inverse Probability Weighting (IPW) estimator first
proposed by Horvitz and Thompson [1952] adjusts empirical estimates according to inverse
sampling probabilities. To estimate generalizable AUC of the model on this intentionally
biased sample, for pairs of subjects i and j, outcome Y and predicted probabilities pˆ, the
IPW-corrected empirical estimator is
AUCIPW =
n∑
i=1
n∑
j=1
pi−1i pi
−1
j I(pˆi > pˆj)I(Yi > Yj)
n∑
i=1
n∑
j=1
pi−1i pi
−1
j I(Yi > Yj)
. (6)
In (6), pii = P (Si = 1) is the sampling probability for subject i, and may be estimated
from observed data for any MAR sample. For the SGS design, pii is additionally known by
construction to be
pii = P (Si = 1|Zi = z) = P (Zi = z|Si = 1)P (Si = 1)
P (Zi = z)
=

R
pZ
× n
N
, Zi = 1
1−R
1− pZ ×
n
N
, Zi = 0.
(7)
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The known sampling probabilities (7) may be directly used in IPW-corrected accuracy met-
rics such as (6). Note that the AUC indexing described in Section 2.3 is slightly different
than the AUC estimator in (6). In Section 2.2, we assumed that the validation sample was
large and representative of the cohort, and represented the effect of development sample
composition on validation AUC. Here, in using (6), we considered the developed model to be
fixed, and studied the effect of validation sample composition towards unbiased estimation
of true model accuracy measures of this fixed model on the target cohort. Our theoretical ar-
guments demonstrate that any introduced bias from using SGS samples for model validation
may be corrected with IPW towards unbiased estimation of model accuracy measures.
2.4.3 Theoretical requirements for design validity
By framing the proposed sampling design as a missing data problem, we have characterized
sampling impact on modeling and outlined several analytic guidelines for design validity. For
model development of classifiers based on conditional outcome distributions, the surrogate
Z needs to be included as a predictor. For model validation, empirical accuracy measures
may be corrected using IPW estimators, where required sampling probabilities are known
exactly by design. For both model development and model validation, subjects representing
surrogate positives (Z=1) and surrogate negatives are (Z=0) are required in the sample. For
example, if only surrogate positives are available, model coefficients are estimable only on
the Z = 1 stratum and pii is undefined for the Z = 0 stratum, without further parametric
assumptions.
3 Simulations
To illustrate the benefit of using SGS designs for statistical machine-learning model develop-
ment, we conducted simulations motivated by a real-world data set of radiology text reports
from the Lumbar Imaging with Reporting of Epidemiology (LIRE) study (Jarvik et al. [2015]
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- for additional information see Section 4). For the simulation study, features were generated
following a long-tail distribution that is characteristic of bag-of-words text data, modeling
was based on penalized regression due to high-dimensional feature assumptions, and we
compared the effect of various sampling designs on validation prediction accuracy.
3.1 Simulation set-up
For cohorts of sizeN = 100, 000, we generated conditional outcomes as independent Bernoulli
random variables, having prevalence of either 5% or 10%. As most EMR datasets contain
features of high dimensionality, we set the number of features to be p = 250, of which
only 30 had non-zero coefficients. Specifically, the conditional outcome was generated as
Yi|
(
Z1i, Z2i, X˜
T
i
)
∼ Bernoulli(P (Yi = 1)), where logit(P (Yi = 1)) = β0+βZ1Z1i+βZ2Z2i+
p∑
j=1
βjXij, with βj = (−0.75,−0.5, 0.25, . . . ,−0.5, 0.25) for the first 20 most frequent features,
βj = 1 for the 10 features with frequencies closest to the outcome prevalence, and βj = 0 for
the remaining 220 features. Here, we used a simplifying assumption that the most predictive
text-based features tend to occur as often as the outcome prevalence, frequent features are
weakly predictive, but most features are irrelevant for predicting the outcome.
Binary features were generated as independent Bernoulli random variables, with marginal
feature frequencies following an exponential distribution simulating a long upper tail distri-
bution, where the most common features are present in almost all reports but the majority
of features have very low frequencies (Sichel [1975]). Specifically, features were generated as
X˜j ∼ Bernoulli
(
px˜j
)
, where px˜j simulated following an exponential distribution with mean
= 1
6
comparable to observed distributions in the LIRE dataset. For the binary enrichment
surrogates, surrogate Z1 had a sensitivity of 0.40 and a specificity of 0.95, defined to have
comparable operating characteristics with the real-world surrogate for the LIRE data set,
while surrogate Z2 had a sensitivity of 0.67 and a specificity of 0.66, and may be viewed as
a “weaker” surrogate for sampling. Note that both surrogates have the same discrimination
17
for the outcome (AUC = 0.67) as computed according to the trapezoidal rule.
We compared the sampling methods: simple random sampling (SRS) which we consider to
be the “baseline”, surrogate-guided sampling designs (SGS), as well as random over-sampling
(ROS) which is a commonly used analysis-based re-sampling procedure. For each simulated
cohort, we set aside a large validation sample with sample size nval = 10000 using SRS.
From the remaining subjects, we simulated “abstraction samples” varying across a grid of
sample sizes, and sampling methods of SRS, ROS, SGS 1:1 or SGS 3:1, where SGS may
be based on surrogates Z1 or Z2. For the SRS and SGS sampling designs, the abstraction
sample size is exactly the development sample size. The ROS procedure replicates cases
from an SRS sample of size n until the number of cases and controls are equal. Therefore,
even though both SRS and ROS have the same “abstraction sample size”, ROS results in
a higher development sample size due to case replication. For a fair comparison, we used
abstraction sample size rather than development sample size as the unit of cost measurement.
For each iterations we fit either Lasso or Ridge classification models, but coefficients for
enrichment surrogates were assigned a zero penalty, which is a modification to the usual
likelihood so that the surrogate is always included in the resulting model. Regularization
parameters were selected based on values that maximized AUC using ten-fold cross-validation
on development samples. Then, we apply resulting model estimates to the validation sample,
calculating the empirical validation AUC using the Wilcoxon-Mann-Whitney formula. Over
all B = 1000 iterations, we calculated average validation AUCs and illustrated results in the
form of learning curves. Briefly, a learning curve is a type of plot in machine-learning to show
the change in model prediction accuracy (here: discrimination) when cost (here: abstraction
sample size) increases. In these experiments, since we compared prediction accuracy across
different sampling designs conditioned on the same models and data generating mechanism,
the difference in model performance is due to differences in the sampling design that gave
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rise to resulting samples.
3.2 Simulation results
Figure 3 illustrates simulation results when modeling with logistic lasso regression. First,
consider the cohort with 5% outcome prevalence and SGS sampling using surrogate Z1 (Fig-
ure 3(a)(i)), where surrogate discrimination for outcome was low but machine-learning may
improve model discrimination. Learning with samples obtained with SRS is difficult, re-
quiring an abstraction sample size of n=3000 to achieve a validation AUC of 0.85 (94% of
the maximum AUC of 0.90). In contrast, using SGS achieves such discrimination at lower
sample sizes, with the SGS 1:1 design requiring n=1500 (50% of SRS cost) and the SGS 3:1
design requiring n=1000 (33% of SRS cost). Notice that while assigning a higher propor-
tion to surrogate positives (SGS 3:1) resulted in slightly higher learning curves compared to
equal proportions of surrogate positives and negatives (SGS 1:1), such differences were less
substantial compared to the difference between using any SGS compared to SRS. We remark
that the benefit of ROS on learning is inconsistent, where such case replication sometimes
resulted in worse generalizable discrimination compared to no replication (SRS) at all.
Figure 3(b)(i) shows the same setting as described before, but SGS sampling was based on
surrogate Z2 rather than Z1. Even though surrogates Z1 and Z2 had the same discrimination
for the outcome (AUC = 0.675), Z2 was a worse variable for stratified sampling purposes.
For a validation AUC of 0.85, using surrogate Z2 based on the SGS 1:1 and SGS 3:1 alloca-
tions required n=2500 (83% of SRS cost) and n=2000 (67% of SRS cost) respectively. Such
differences may be attributed to the lower specificity of surrogate Z2 compared to Z1, re-
sulting in overall lower sample prevalence and therefore reduced benefit for learning. Similar
results on SGS design benefit and surrogate specificity were observed for the cohort having
10% outcome prevalence (Figures 3(a)(ii) and 3(b)(ii)), but SGS design benefit over SRS was
less pronounced due to a less rare outcome. To achieve a validation AUC of 0.85 with lasso
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regression, using SRS required an abstraction sample size of n=1000 while using SGS 1:1
sampling based on surrogate Z1 and Z2 required n=700 and n=900 respectively, compared
to sample size savings of 50% and 83% respectively for the 5% outcome scenario.
Figure 4 illustrates learning curves for modeling with logistic ridge regression, with SGS us-
ing surrogate Z1 (Figure 4(a)) and Z2 (Figure 4(b)). Compared to using lasso regression, the
different shapes of learning curves reflected differences in choice of modeling using variable
selection versus shrinkage. To achieve a validation AUC of 0.85 for the 5% outcome preva-
lence cohort, learning with SRS required an abstraction sample size of at least n=4000 while
SGS sampling using surrogate Z1 required about n=2500 (less than 63% of SRS cost), where
using SGS regardless of stratification allocation was a consistent improvement over SRS. On
the other hand, SGS sampling using surrogate Z2 had almost the same sample size require-
ment as with SRS, again emphasizing the importance of surrogate specificity for sampling.
Similar conclusions were observed for the 10% outcome prevalence cohort. When modeling
with ridge regression, ROS was consistently worse than SRS without case replication. One
possible explanation is due to that using ridge regression reduces the estimation variance
of classification through intentionally biased estimates. With over-sampling, while modeling
bias increases, variation remains the same as case replication does not provide additional
information, therefore resulting in lower generalizable prediction accuracy.
Therefore, our results suggest three consistent patterns associated with SGS sampling. First,
using SGS for sampling was generally an improvement over using SRS for classification of
rare outcomes, as observed for both lasso and ridge regression learning. Second, allocating
higher proportions to the surrogate positive stratum resulted in improved learning compared
to equal allocations, but only slightly. Third, using a more specific surrogate results in a
sample with higher information and therefore improved learning compared to using a less
specific surrogate. We acknowledge that quantification of the exact design benefit on learning
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depends on factors such as the specific modeling choice and the outcome prevalence.
4 Application: Fracture identification from radiology
reports
4.1 Data set details
Vertebral fractures of the spine can lead to spinal deformity, loss of vertebral height, crowding
of internal organs, and loss of muscles, resulting in acute back pain and potentially chronic
pain. Diagnosis is usually made through radiographic imaging, such as with plain x-ray or
magnetic resonance imaging (MRI). In EMR systems a vertebral fracture finding is natively
captured in unstructured text form, and for research a definite fracture status variable re-
quires clinical expert abstraction of associated radiology text reports. Therefore, sampling
strategies alternative to the usual SRS may be reduce the abstraction burden towards accu-
rate and scalable machine-learning classification of vertebral fracture outcomes.
The Lumbar Imaging with Reporting of Epidemiology (LIRE) study evaluated the effect of
radiology report content on subsequent treatment decisions among adult subjects (Jarvik
et al. [2015]). Subjects were eligible for the LIRE study if they had a diagnostic imaging test
ordered by their Primary Care Physician (PCP), so all subjects in LIRE had at least one
radiology report available from the EMR database. The prevalence of vertebral fractures
is estimated to be relatively rare: 3-20% among primary care subjects seeking care for all
reasons (Waterloo et al. [2012]) and expected to be similar among subjects from the LIRE
study. Using LIRE data as the “cohort”, we evaluate the benefit of using SGS designs for
outcome label abstraction and subsequent classification model development.
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4.2 Surrogate creation and sampling design application
Together with clinicians, we identified a set of 26 International Classification of Disease
(ICD) codes that if present, are highly likely to indicate that a subject was diagnosed with
a vertebral fracture; details are in Supplementary Material C. For each subject, we counted
how many ICD codes were noted in the EMR within 90 days of cohort entry. In the co-
hort of 178,333 subjects, 171,592 (96%) did not have any relevant ICD codes, 3,275 (1.83%)
had one code, 1,303 (0.73%) had two codes, 758 (0.42%) had three codes, and the remain-
ing had more than three codes. Since most subjects did not have any relevant ICD codes
and a count of one was the most common count, we defined the enrichment surrogate Z as
Zi = I(count vertebral fracture ICD codes within 90 days for subject i > 1), where 3.78%
of the cohort were considered to be “surrogate positives”.
This abstraction task was nested within a larger abstraction set-up for the LIRE study. The
radiology reports of each selected subject were abstracted by two independent clinicians for
the presence or absence of vertebral fractures. From the available dataset, data “marts”
for model development and model validation were assembled, each having a sample size
of n=500. The validation data mart was selected such that it was representative of the
underlying cohort, while the development data mart was selected based on an SGS 1:1
configuration. Using the validation data mart, we estimated marginal characteristics of the
surrogate as well as the Oratio of the resulting SGS design.
4.3 Modeling and analysis
Features were created by processing radiology report text data using the quanteda package
in R. Features were bag-of-words (BOW) unigrams excluding typical English stopwords as
well as terms that were very rare (< 5% of all reports) or common (> 90% of all reports).
We used the term-frequency inverse-document frequency (TF-IDF) representation for BOW
as described in Salton and Buckley [1988], which incorporates information about the impor-
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tance of terms both locally (within a single report) as well as globally (across all reports).
For a collection of N reports denoted d1, . . . , dN , the set of p terms denoted T = {t1, . . . , tp}
was obtained from concatenating unique words from all reports. Then the TF-IDF feature
matrix X contains elements Xij = TF (di, tj) × IDF (tj), with term frequency TF defined
as TF (tj, di) = 1 + log(1 +
Count(tj∈di)
|di| ) and inverse document frequency IDF defined as
IDF (tj) = log
 N
N∑
i=1
I(tj∈di)
. In addition to text-features, we also included the binary en-
richment surrogate Z as a predictor, for a total of p = 298 features.
To investigate the design effect on model prediction accuracy, we drew B = 1000 bootstrap
samples of sizes n = 100, 250, 500 from the development data mart stratified by surrogate
status. To simulate the SRS design, we drew samples according to an “inverse SGS” design
from the development data mart, where surrogate positives were under-included with the
sampling probabilities (7). To simulate the SGS design, we drew samples randomly from
the development data mart. For each simulated sample, we fitted Lasso logistic regression
selecting regularization parameter λ based on minimizing the average 10-fold cross-validated
error using an AUC loss function. Resulting estimated model parameters were then applied
to the validation sample to obtain estimates of the validation AUC. For each sampling de-
sign (SRS and SGS) and for each sample size, we reported mean validation AUC and 95%
bootstrap confidence intervals.
Estimated data set characteristics are shown in Table 1. Note that the defined enrichment
surrogate by itself had low AUC in discriminating the outcome. In fact, its operating char-
acteristics were such that it was highly specific but only moderately sensitive for the finding,
an overall high Oratio for the resulting SGS design. Even though only a weak predictor, the
surrogate is beneficial as a sampling variable. Data analysis results are shown in Table 2.
In general, when fitting a logistic lasso regression, average validation AUC increases with
sample size. However, for the same sample size, using samples drawn with SGS resulted in
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higher average validation AUC. For example, using the same sample size of n = 250, the
AUC of SGS was 0.86 while that of SRS was only 0.74, a difference of 0.12 suggesting that
allocating a sample size of 250 is more resource efficient under SGS compared to SRS.
5 Discussion
In summary, motivated by sampling frameworks from epidemiology and machine-learning,
we formalized a design strategy for abstraction selection and label collection of rare out-
comes through a two-phase stratified sampling framework. We have demonstrated that the
specificity of a sampling variable used to guide sampling greatly affects design benefit for
classification accuracy. We suggest that a specificity of 0.95 or higher is ideal, 0.80 is very
good, and 0.50 is the absolute minimum specificity that a surrogate needs to achieve in order
to be considered as a sampling variable. To create highly specific surrogates, simple key-
word searches may be supplemented with off-the-shelf negation tools for example in Harkema
et al. [2009], while related ICD codes may be defined with higher count thresholds within
a shorter period of time. Additionally, keywords and ICD codes may be combined with an
“AND” query to further increase specificity. To estimate the specificity of a candidate surro-
gate, a small initial sample may be collected using SGS, where we remark that appropriate
estimators may be based on those described in the verification bias literature (Alonzo [2014]).
The are two practical trade-offs of the proposed design worth considering. First, a concern
may be whether sampling on a highly specific surrogate could result in a dataset that is
sufficiently representative of all possible outcome subgroups. For example, in the vertebral
fracture data application, while requiring at least two instead of one ICD codes may further
increase surrogate specificity, such a strategy could have resulted in a sample with mostly
chronic fractures and not acute fractures. A possible solution may implement a “tiered”
surrogate, using sub-samples defined by variables to balance specificities and case repre-
24
sentativeness (e.g. > 2, 1, 0 counts of ICD codes). Another trade-off relates to strata
proportions. While increasing sample surrogate positives may result in slightly improved
classification accuracy, resulting inflated inverse weights may greatly increase the variance
of IPW estimators of validation accuracy measures.
Anchored in the proposed SGS design framework, future work may formally investigate
methodological and practical questions related to full study planning such as formal sample
size calculations. Once relevant trade-offs are carefully defined, appropriate sample size cal-
culations may then proceed taking into account the need of both model development and
model validation. Other future work should include: investigating the appropriateness of the
SGS framework for outcomes that are much rarer than what we considered (5%); character-
izing design effects on prediction accuracy measures other than AUC; as well as determining
best practices for sampling in the presence of site heterogeneity. Ultimately, our hope is to
encourage careful statistical and study design thinking when assembling labeled data sets
for machine-learning model development and validation, especially when considering the
non-trivial abstraction cost in obtaining such labels.
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Figure 1: Expected sample case proportions (shaded regions) for simple random sampling
(SRS) and surrogate-guided sampling (SGS) designs with 1:1 and 3:1 ratio of surrogate
positive to negative in the sample. Illustrations are based on a scenario with outcome
prevalence 10%, and surrogate with sensitivity 40% and specificity 95% for the outcome of
interest.
(a) SRS.
Z=0
Z=1
(b) SGS 1:1.
Z=0
Z=1
(c) SGS 3:1
Z=0
Z=1
Figure 2: Oratio values for surrogates of different marginal sensitivity and specificity, based
on a fixed R = 0.50 and an outcome with prevalence of 10%.
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Figure 3: Logistic Lasso Regression learning curves (outcome prevalence = 5%) comparing
simple random sampling (SRS), random over-sampling (ROS), and surrogate-guided sam-
pling (SGS) with 1:1 or 3:1 ratio of surrogate positives to negatives. Surrogate Z1 had
sensitivity = 0.40 and specificity = 0.95, while surrogate Z2 had sensitivity = 0.67 and a
specificity = 0.66.
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Figure 4: Logistic Ridge Regression learning curves (outcome prevalence = 5%) comparing
simple random sampling (SRS), random over-sampling (ROS), and surrogate-guided sam-
pling (SGS) with 1:1 or 3:1 ratio of surrogate positives to negatives. Surrogate Z1 had
sensitivity = 0.40 and specificity = 0.95, while surrogate Z2 had sensitivity = 0.67 and a
specificity = 0.66.
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Table 1: Estimated data set characteristics for radiology reports drawn from the LIRE data
set: Sensitivity, specificity, AUC, and Likelihood Ratios of the defined surrogate, as well
as the Oratio of resulting surrogate-guided sampling (SGS) design. 95% confidence intervals
were based on B=1000 bootstrap resamples.
Surrogate or design metric Estimate (95% C.I.)
Sensitivity of Z 0.27 (0.18, 0.36)
Specificity of Z 0.99 (0.99, 1)
AUC of Z 0.633 (0.58, 0.68)
LR+ of Z 26 (18, 41)
LR− of Z 1.36 (1.22, 1.57)
Oratio using SGS with 1:1 ratio of Z = 1 and Z = 0 7.13 (5.65, 9.04)
Table 2: Average validation AUC (95% C.I.) for various training sample sizes, based on
B=1000 bootstrap resamples, for illustration of surrogate-guided sampling (SGS) designs on
radiology reports drawn from the LIRE data set.
Training sample size ˆAUC(DSRS(n)) ˆAUC(DSGS(n))
100 0.68 (0.50, 0.90) 0.76 (0.63, 0.88)
250 0.74 (0.50, 0.92) 0.86 (0.79, 0.91)
500 0.83 (0.50, 0.92) 0.88 (0.85, 0.91)
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A Proof of Theorem 2.1
Denote the cohort data as D = (X, Y ), consisting of features X (implicitly also including
the surrogate Z), and binary outcomes Y . From D, units (typically subjects) are selected
to form development and validation samples.
A.1 Preliminaries
In D, let the features follow a bi-normal distribution, so that for y ∈ {0, 1}
(X|Y = y) ∼ N(µx|y,Σx|y) (1)
This is equivalent to a Linear Discriminant Analysis (LDA) setting, where
logit(E[Y |X]) = β0 + βTX
β0 = log
(
pi1
pi0
)
− 1
2
(µx|y1 + µx|y0)TΣ−1x|y(µx|y1 − µx|y0)
βT = Σ−1x|y(µx|y1 − µx|y0).
(2)
The parameters in (2) are true parameters in D. To estimate regression coefficients, a sample
DS(n) needs to be drawn from D. Then, based on theory from generalized linear models,
the resulting estimate βˆ has the following first and second moments:
ED
S(n)[βˆ] = β +BiasD
S(n)(βˆ)
V arD
S(n)(βˆ) = (XsTWXs)−1.
(3)
In (3), W = Diag(pi(1 − pi)), where pi = P (Yi = 1|X, Si = 1; β) estimates the average
probabilities resulting from the sigmoidal transformation of development sample linear pre-
dictions. The terms in (3) are accurate up to second order approximations. In estimating the
regression parameters, denote the bias BiasD
S(n)(βˆ) as B(βˆS(n)) and variance V arD
S(n)(βˆ)
as V (βˆS(n)), then both B(βˆS(n)) and V (βˆS(n)) depend on the development sample DS(n)
through sample size n and sampling design S. To evaluate the resulting classification model,
we use a large validation sample, obtained using simple random sampling from D. Denote
the true linear predictions in the validation sample as η := Xvβ, with distribution
Xvβ ∼ N(µy, σ2y)
µy = µ
T
x|yβ; σ
2
y = β
TΣx|yβ
for y ∈ {0, 1}, where µx|y and Σx|y were defined in (1). Under the bi-normal ROC assumption
Pepe [2003], the AUC is
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AUC = Φ(
√
RAUC) = Φ
(√
(µ1 − µ0)2
σ21 + σ
2
0
)
.
In the classification setting, coefficients are estimated from the development sample DS(n),
where DS(n) is generated with sampling design S and with development sample size n. We
use AUC(Y |DS(n)) to denote an indexing of resulting validation AUC, where
AUC(Y |DS(n)) = Φ(
√
RAUC(DS(n)))
RAUC(D
S(n)) =
(µˆ1 − µˆ0)2
σˆ21 + σˆ
2
0
.
(4)
In (5), the notation .ˆ and DS(n) indicates that the estimation of βˆ is from DS(n). This
proof outlines AUC(DS(n)) in terms of development sample composition.
A.2 Mean and variances of validation sample linear predictions
In the large and representative validation sample, for y ∈ {0, 1}, the mean of the estimated
linear predictions is
µˆy = E
DS(n),Xv [Xvβˆ|Y v = y]
= EX
v
ED
S(n)|Xv [Xvβˆ|Y v = y]
= EX
v
[Xv(β +B(βˆS(n)))|Y v = y]
= µTx|y(β +B(βˆ
S(n))).
(5)
where the double expectation is due to the dependence on validation sample features Xv as
well as development sample estimated coefficients βˆ. Similarly, the variance of the estimated
linear predictions is
σˆ2y = V ar
DS(n),Xv(Xvβˆ|Y v = y)
= V arX
v
(ED
S(n)|Xv [Xvβˆ|Y v = y]) + EXv [V arDS(n)|Xv(Xvβˆ|Y v = y)]
(6)
The first part of the right hand side of (6) is
V arX
v
(ED
S(n)|Xv [Xvβˆ|Y v = y]) = V arXv(Xv(β +B(βˆS(n)))|Y v = y)
= (β +B(βˆS(n)))TΣx|y(β +B(βˆS(n))),
(7)
and the second part of the right hand side of (6) is
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EX
v
[V arD
S(n)|Xv(Xvβˆ|Y v = y)] = EXv [XvTV (βˆS(n))Xv|Y v = y]
= trace(V (βˆS(n))Σx|y) + µTx|yV (βˆ
S(n))µx|y,
(8)
where we have used properties of the expectation of a quadratic form: for  ∼ (µ,Σ), E[TΛ] =
trace(ΛΣ) + µTΛµ. Therefore, combining (7) and (8), the variance of η is
σˆ2y = V ar
Xv(ED
S(n)|Xv [Xvβˆ|Y v = y]) + EXv [V arDS(n)|Xv(Xvβˆ|Y v = y)]
= (β +B(βˆS(n)))TΣx|y(β +B(βˆS(n))) + trace(V (βˆS(n))Σx|y) + µTx|yV (βˆ
S(n))µx|y.
(9)
A.3 Classifier validation AUC in terms of estimation variance
Now we plug in values for (4). WLOG assume that µx|y0 = 0 and that Σx|y=1 = Σx|y=0 =
Σx|y. Then, the means and variances of validation sample linear predictions among cases
(Y=1) and controls (Y=0) are respectively
µˆ1 = µ
T
x|y1(β +B(βˆ
S(n)))
µˆ0 = 0
σˆ21 = (β +B(βˆ
S(n)))TΣx|y(β +B(βˆS(n))) + trace(cΣx|y) + µTx|y1V (βˆ
S(n))µx|y1
σˆ20 = (β +B(βˆ
S(n)))TΣx|y(β +B(βˆS(n))) + trace(V (βˆS(n))Σx|y).
(10)
Thus, the numerator in (4) is the square of
µˆ1 − µˆ0 = µx|y1(β +B(βˆS(n))), (11)
while the denominator in (4) is
σˆ21 + σˆ
2
0 = 2{(β +B(βˆS(n)))TΣx|y(β +B(βˆS(n))) + trace(V (βˆS(n))Σx|y)}+ µTx|y1V (βˆS(n))µx|y1. (12)
Thus, based on (4), (11), and (12), since Φ(.) and
√
(.) are monotone transformations,
AUC(Ds(n)) =
(µx|y1(β +B(βˆS(n))))2
2((β +B(βˆS(n)))TΣx|y(β +B(βˆS(n))) + trace(V (βˆS(n))Σx|y)) + µTx|y1V (βˆ
S(n))µx|y1
.
When B(βˆS(n)) ≈ 0, then since β, µx|y and Σx|y are assumed to be “fixed” quantities in a
large validation sample,
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AUC(Ds(n)) ∝ 1
trace(V (βˆS(n))Σx|y)) + µTx|y1V (βˆ
S(n))µx|y1
.
35
B Derivation of Proposition 2.1
For Y ∈ {0, 1}, E[Y ] = P (Y = 1). Denote subjects where S = 1 as those included
in DSGS(n), the SGS sample selected from the cohort only based on values of Z. Thus,
S ⊥ Y |Z. The expected case odds in samples collected using SGS is
Odds(cases|SGS) = E
DSGS(n)[Y |S = 1]
1− EDSGS(n)[Y |S = 1] =
P (Y = 1|S = 1)
P (Y = 0|S = 0)
=
P (Y = 1|S = 1, Z = 1)P (Z = 1|S = 1) + P (Y = 1|S = 1, Z = 0)P (Z = 0|S = 1)
P (Y = 0|S = 1, Z = 1)P (Z = 1|S = 1) + P (Y = 0|S = 1, Z = 0)P (Z = 0|S = 1)
=
P (Y = 1|Z = 1)P (Z = 1|S = 1) + P (Y = 1|Z = 0)P (Z = 0|S = 1)
P (Y = 0|Z = 1)P (Z = 1|S = 1) + P (Y = 0|Z = 0)P (Z = 0|S = 1)
=
P (Y = 1)
P (Y = 0)
R
P (Z = 1|Y = 1)
P (Z = 1)
+ (1−R)P (Z = 0|Y = 1)
P (Z = 0)
R
P (Z = 1|Y = 0)
P (Z = 1)
+ (1−R)P (Z = 0|Y = 0)
P (Z = 0)
=
P (Y = 1)
P (Y = 0)
R(1− P (Z = 1))Zsens + P (Z = 1)(1−R)(1− Zsens)
R(1− P (Z = 1))(1− Zspec) + P (Z = 1)(1−R)(Zspec)
=
P (Y = 1)
P (Y = 0)
RZsens + pZ(1−R− Zsens)
R(1− Zspec) + pZ(Zspec −R)
where
R = P (Z = 1|S = 1)
pZ = P (Z = 1)
Zsens = P (Z = 1|Y = 1)
Zspec = P (Z = 0|Y = 0).
The expected case odds in samples collected using SRS is
Odds(cases|SRS) = E
DSRS(n)[Y |S = 1]
1− EDSRS(n)[Y |S = 1]
=
P (Y = 1)
P (Y = 0)
.
Then, the case/control odd ratio of samples obtained with SGS compared to that of SRS is:
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Oratio =
ED
SGS(n)[Y |S = 1]
1− EDSGS(n)[Y |S = 1]/
ED
SRS(n)[Y |S = 1]
1− EDSRS(n)[Y |S = 1]
=
ED
SGS(n)[Y |S = 1]
1− EDSGS(n)[Y |S = 1]/
P (Y = 1)
P (Y = 0)
=
RZsens + pZ(1−R− Zsens)
R(1− Zspec) + pZ(Zspec −R) .
(1)
Assume that the outcome is rare, so P (Y = 1) ≈ 0. Then, a linear approximation of (1) is
Oratio =
RZsens + pZ(1−R− Zsens)
R(1− Zspec) + pZ(Zspec −R)
=
R
1− P (Y = 1|Z = 1)(LR+) +
1−R
P (Y = 0|Z = 0)(LR−)
R
1− P (Y = 1|Z = 1) +
1−R
P (Z = 0|Y = 0)
≈(R)(LR+) + (1−R)(LR−)
(2)
where
LR+ =
P (Z = 1|Y = 1)
P (Z = 1|Y = 0) =
Zsens
1− Zspec =
P (Y = 1|Z = 1)
P (Y = 0|Z = 1)
P (Y = 1)
P (Y = 0)
LR− = P (Z = 0|Y = 1)
P (Z = 0|Y = 0) =
1− Zsens
Zspec
=
P (Y = 1|Z = 0)
P (Y = 0|Z = 0)
P (Y = 1)
P (Y = 0)
LR+ and LR− are the likelihood ratios of the surrogate Z in predicting the outcome Y
among surrogate positives and negatives, respectively.
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C Details of enrichment surrogate for data application
Table 3 shows details of the set of ICD codes used to construct an enrichment surrogate
which is used for collecting reports that are more likely to contain vertebral fracture. The
enrichment surrogate was defined as
Zi = I((count vertebral fracture ICD codes in Table 3 within 90 days for subject i) > 1).
Table 3: Set of International Classification of Disease (ICD) codes used to define enrichment
surrogate
ICD code Long description
806.25 Closed fracture of T7-T12 level with unspecified spinal cord injury
806.26 Closed fracture of T7-T12 level with complete lesion of cord
806.27 Closed fracture of T7-T12 level with anterior cord syndrome
806.28 Closed fracture of T7-T12 level with central cord syndrome
806.29 Closed fracture of T7-T12 level with other specified spinal cord injury
806.35 Open fracture of T7-T12 level with unspecified spinal cord injury
806.39 Open fracture of T7-T12 level with other specified spinal cord injury
806.4 Closed fracture of lumbar spine with spinal cord injury
806.5 Open fracture of lumbar spine with spinal cord injury
806.6 Closed fracture of sacrum and coccyx with unspecified spinal cord injury
806.61 Closed fracture of sacrum and coccyx with complete cauda equina lesion
806.62 Closed fracture of sacrum and coccyx with other cauda equina injury
806.69 Closed fracture of sacrum and coccyx with other spinal cord injury
806.8 Closed fracture of unspecified vertebral column with spinal cord injury
806.9 Open fracture of unspecified vertebral column with spinal cord injury
733.13 Pathologic fracture of vertebrae
805.4 Closed fracture of lumbar vertebra without mention of spinal cord injury
805.5 Open fracture of lumbar vertebra without mention of spinal cord injury
805.6 Closed fracture of sacrum and coccyx without mention of spinal cord injury
805.7 Open fracture of sacrum and coccyx without mention of spinal cord injury
805.8 Closed fracture of unspecified vertebral column without mention of spinal cord injury
805.9 Open fracture of unspecified vertebral column without mention of spinal cord injury
809 Fracture of bones of trunk, closed
809.1 Fracture of bones of trunk, open
V54.17 Aftercare for healing traumatic fracture of vertebrae
V54.27 Aftercare for healing pathologic fracture of vertebrae
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